HUDSON, N.Y., May 03, 2017 -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it will expand the offering of a key Alzheimer’s Disease (AD) mouse model, APPSWE - Model 1349, to include aged animals.
Taconic will now offer off-the-shelf Model 1349 animals aged up to 42 weeks, saving months off the typical timeline to access Alzheimer’s models. This program addresses customers’ need to have critical disease models immediately available, as opposed to placing an order and waiting for the animals to age and express the desired phenotype.
Dr. Michael Seiler, Taconic Biosciences’ portfolio director for genetically engineered models, commented, “The addition of aged APPSWE animals demonstrates Taconic’s commitment to help researchers reduce discovery timelines. These reductions save both time and money, ultimately making it easier to progress towards life-changing therapeutics.”
APPSWE mice express a mutated form of the human gene for amyloid precursor protein (APP) known as the Swedish mutation (APPSWE). The mutated gene encodes a double amino acid substitution and is associated with an inheritable increased susceptibility to Alzheimer’s Disease. Resulting phenotypic manifestations in APPSWE mice include a progressive accumulation of beta amyloid (Aβ) in the brain, analogous to classic “senile plaques” of human AD, and correlated cognitive deficits. Mice that overexpress an Alzheimer’s-associated isoform of the human amyloid precursor protein provide a model for human Alzheimer’s Disease and an experimental tool for a diversity of cellular mechanisms.
Alzheimer’s Disease and other dementias is expected to cost the United States $259 billion dollars in 2017 (www.alz.org), representing a major market and focus for pharmaceutical research.
Taconic also offers unaged Model 1349 animals, as well as a comprehensive neuroscience rodent model portfolio. To learn more about Taconic’s neuroscience portfolio, please contact Taconic Biosciences at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe or at [email protected]
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact: Kelly Owen Grover Director of Marketing Communications (518) 697-3824 [email protected]


AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown 



